Alloimmune responses in particular may facilitate the induction of autoimmune responses to self-antigens and these can then collectively lead to chronic rejection. Both ColV and Kα1T are ...

While I understand the methodological challenge for NICE, the fact is that NHS data show that patients with this type of lung cancer survive for 17 months, which is within the 24-month short life ...

Neoantigen vaccine is a promising breakthrough in tumor immunotherapy. However, the application of this highly personalized strategy in the treatment of solid tumors is hindered by several obstacles, ...

That's what happened when I came across heat shock proteins. I was a postdoc at Sloan Kettering in 1985, and I had just received the results of the N-terminal sequence of gp96, a tumor-rejection ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...

Members of the surgical team told reporters that the pig liver successfully secreted bile and showed no signs of rejection over ... Researchers found that tick antigens were trying to suppress ...

including non-small cell lung cancer and head and neck cancer. It utilizes mRNA encoding multiple TAAs encapsulated in a lipid nanoparticle (LNP) delivery system. Following intramuscular injection, ...

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical ...

EVM14 received U.S. FDA clearance for its IND application, becoming Everest’s first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical ...